NEW YORK, NY–(Newsfile Corp. – January 4, 2025) – Why: The Rosen Law Firm, a global investor rights law firm, reminds purchasers of AstraZeneca PLC’s (NASDAQ: LON: ) securities from February 23, 2022 to December 17, 2024, both dates inclusive (the “Class Period”). February 21, 2025 lead plaintiff deadline In a securities class action first filed by a firm.
So what? If you purchased AstraZeneca (NASDAQ: ) securities during the class period, you may be entitled to compensation without paying out-of-pocket taxes or expenses under a contingency fee arrangement.
What should we do next? To join the AstraZeneca class action, go to https://rosenlegal.com/submit-form/?case_id=1331 or call Philip Kim, Esq. Toll free at 866-767-3653 or email case@rosenlegal.com for class action information. A class action lawsuit has already been filed. If you want to be the lead plaintiff, you have to move the court No later than February 21, 2025. A lead plaintiff is a representative party acting on behalf of other class members in litigation.
Why the Law of Roses: We encourage investors to choose a qualified consultant to succeed in leadership roles. Often, messaging firms do not have comparable experience, resources, or any significant peer recognition. Many of these firms do not actually litigate securities class actions, but are merely intermediaries who refer clients or partner with the law firms that actually litigate the cases. Be wise in your choice of advice. The Rosen Law Firm represents investors worldwide, concentrating its practice in securities class actions and shareholder derivative litigation. The Rosen law firm achieved the largest securities class action against a Chinese company at the time. Law firm Rosen took first place in the ISS Securities category action (WA:) Services for Securities Class Settlements in 2017. The firm has been in the top 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the firm secured more than $438 million for investors. In 2020, founding partner Laurence Rosen was named a plaintiffs’ attorney titan by law360. Many of the firm’s attorneys are recognized by Lawdragon and Super Lawyers.
Details of the case: According to the lawsuit, the defendants throughout the class period made materially false and/or misleading statements and/or failed to disclose that: (1) AstraZeneca engaged in insurance fraud in China; (2) as a result, AstraZeneca faced increased legal exposure in China, which ultimately resulted in the arrest of AstraZeneca’s China President by Chinese law enforcement; (3) as a result, AstraZeneca assessed its legal risks; (4) the foregoing, once disclosed, could materially harm AstraZeneca’s business operations in China; and (5) as a result, Defendants’ statements about its business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit alleges, investors were harmed.
To join the AstraZeneca class action, go to https://rosenlegal.com/submit-form/?case_id=1331 Call Philip Kim, Esq. Toll free at 866-767-3653 or email case@rosenlegal.com for class action information.
No classes have been certified. Until the class is certified, you are not represented by an attorney unless you retain one. You can choose the favorite of your choice. You can also stay in the absent class and do nothing at this point. An investor’s ability to participate in any potential future recovery is not dependent on being the lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ:): https: / /www.facebook.com/rosenlawfirm.
Lawyer advertisement. Previous results do not yield similar results.
——————————
Contact information:
To view the source version of this press release, visit https://www.newsfilecorp.com/release/236060